178 related articles for article (PubMed ID: 36171522)
41. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
42. Current status and future directions of fish vaccines employing virus-like particles.
Jeong KH; Kim HJ; Kim HJ
Fish Shellfish Immunol; 2020 May; 100():49-57. PubMed ID: 32130976
[TBL] [Abstract][Full Text] [Related]
43. Modular Hepatitis B Virus-like Particle Platform for Biosensing and Drug Delivery.
Hartzell EJ; Lieser RM; Sullivan MO; Chen W
ACS Nano; 2020 Oct; 14(10):12642-12651. PubMed ID: 32924431
[TBL] [Abstract][Full Text] [Related]
44. Development of a Versatile Method to Construct Direct Electron Transfer-Type Enzyme Complexes Employing SpyCatcher/SpyTag System.
Yanase T; Okuda-Shimazaki J; Asano R; Ikebukuro K; Sode K; Tsugawa W
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768169
[TBL] [Abstract][Full Text] [Related]
45. A Plant-Produced Virus-Like Particle Displaying Envelope Protein Domain III Elicits an Immune Response Against West Nile Virus in Mice.
Stander J; Chabeda A; Rybicki EP; Meyers AE
Front Plant Sci; 2021; 12():738619. PubMed ID: 34589108
[TBL] [Abstract][Full Text] [Related]
46. Site-Specific Fluorescent Labeling of Antibodies and Diabodies Using SpyTag/SpyCatcher System for In Vivo Optical Imaging.
Alam MK; El-Sayed A; Barreto K; Bernhard W; Fonge H; Geyer CR
Mol Imaging Biol; 2019 Feb; 21(1):54-66. PubMed ID: 29948640
[TBL] [Abstract][Full Text] [Related]
47. Advanced Fusion Strategies for the Production of Functionalized Potato Virus X Virions.
Dickmeis C; Commandeur U
Methods Mol Biol; 2022; 2480():215-239. PubMed ID: 35616866
[TBL] [Abstract][Full Text] [Related]
48. One-step purification and immobilization of recombinant proteins using SpyTag/SpyCatcher chemistry.
Tian J; Jia R; Wenge D; Sun H; Wang Y; Chang Y; Luo H
Biotechnol Lett; 2021 May; 43(5):1075-1087. PubMed ID: 33591462
[TBL] [Abstract][Full Text] [Related]
49. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
Garg H; Sedano M; Plata G; Punke EB; Joshi A
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
[TBL] [Abstract][Full Text] [Related]
50. Induction of adaptive immune responses against antigens incorporated within the capsid of simian virus 40.
Saika K; Kato M; Sanada H; Matsushita S; Matsui M; Handa H; Kawano M
J Gen Virol; 2020 Aug; 101(8):853-862. PubMed ID: 32501197
[TBL] [Abstract][Full Text] [Related]
51. Oral immunization with cell-free self-assembly virus-like particles against orange-spotted grouper nervous necrosis virus in grouper larvae, Epinephelus coioides.
Chien MH; Wu SY; Lin CH
Vet Immunol Immunopathol; 2018 Mar; 197():69-75. PubMed ID: 29475509
[TBL] [Abstract][Full Text] [Related]
52. Controlling macromolecular topology with genetically encoded SpyTag-SpyCatcher chemistry.
Zhang WB; Sun F; Tirrell DA; Arnold FH
J Am Chem Soc; 2013 Sep; 135(37):13988-97. PubMed ID: 23964715
[TBL] [Abstract][Full Text] [Related]
53. Head-to-Head Comparison of Modular Vaccines Developed Using Different Capsid Virus-Like Particle Backbones and Antigen Conjugation Systems.
Fredsgaard L; Goksøyr L; Thrane S; Aves KL; Theander TG; Sander AF
Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34063871
[TBL] [Abstract][Full Text] [Related]
54. Comparison of Bacterial Expression Systems Based on Potato Virus Y-like Particles for Vaccine Generation.
Ogrina A; Skrastina D; Balke I; Kalnciema I; Jansons J; Bachmann MF; Zeltins A
Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455234
[TBL] [Abstract][Full Text] [Related]
55. A novel rapid modularized hepatitis B core virus-like particle-based platform for personalized cancer vaccine preparation via fixed-point coupling.
Ji M; Zhu J; Xie XX; Liu DQ; Wang B; Yu Z; Liu RT
Nanomedicine; 2020 Aug; 28():102223. PubMed ID: 32422220
[TBL] [Abstract][Full Text] [Related]
56. Novel subunit vaccine with linear array epitope protect giant grouper against nervous necrosis virus infection.
Lin CF; Jiang HK; Chen NC; Wang TY; Chen TY
Fish Shellfish Immunol; 2018 Mar; 74():551-558. PubMed ID: 29355759
[TBL] [Abstract][Full Text] [Related]
57. Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana.
Veerapen VP; van Zyl AR; Wigdorovitz A; Rybicki EP; Meyers AE
Virus Res; 2018 Jan; 244():213-217. PubMed ID: 29196195
[TBL] [Abstract][Full Text] [Related]
58. Modular vaccine platform based on the norovirus-like particle.
Lampinen V; Heinimäki S; Laitinen OH; Pesu M; Hankaniemi MM; Blazevic V; Hytönen VP
J Nanobiotechnology; 2021 Jan; 19(1):25. PubMed ID: 33468139
[TBL] [Abstract][Full Text] [Related]
59. SpyTag-SpyCatcher Chemistry for Protein Bioconjugation In Vitro and Protein Topology Engineering In Vivo.
Wang XW; Zhang WB
Methods Mol Biol; 2019; 2033():287-300. PubMed ID: 31332761
[TBL] [Abstract][Full Text] [Related]
60. RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge.
Wong TY; Russ BP; Lee KS; Miller OA; Kang J; Cooper M; Winters MT; Rodriguez-Aponte SA; Dalvie NC; Johnston RS; Rader NA; Wong ZY; Cyphert HA; Martinez I; Shaligram U; Batwal S; Lothe R; Chandrasekaran R; Nagar G; Rajurkar M; Rao H; Bevere JR; Barbier M; Love JC; Damron FH
mSphere; 2022 Aug; 7(4):e0024322. PubMed ID: 35968964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
